Medgend Icon

Ledgend of Medicine







discontinued


Decaspray

Cushing's syndrome is a hormonal disorder. The cause is long-term exposure to too much cortisol, a hormone that your adrenal gland makes. Sometimes, taking synthetic hormone medicine to treat an inflammatory disease leads to Cushing's. Some kinds of tumors produce a hormone that can cause your body to make too much cortisol.

Cushing's syndrome is rare. Some symptoms are:

  • Upper body obesity
  • Thin arms and legs
  • Severe fatigue and muscle weakness
  • High blood pressure
  • High blood sugar
  • Easy bruising

Lab tests can show if you have it and find the cause. Your treatment will depend on why you have too much cortisol. If it is because you have been taking synthetic hormones, a lower dose may control your symptoms. If the cause is a tumor, surgery and other therapies may be needed.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Decaspray FDA Approved Drugs

DEXAMETHASONE [DexamethasoneC22H29FO5]
RX
-
0.5mg (oral tablet)
0.5mg/5ml (oral elixir)
0.75mg (oral tablet)
1.5mg (oral tablet)
1mg (oral tablet)
2mg (oral tablet)
4mg (oral tablet)
6mg (oral tablet)
Par PharmApr 28, 1983
West-ward Pharms IntApproved Prior To Jan 1, 1982
LyneJul 12, 2011
Sti Pharma LlcApproved Prior To Jan 1, 1982
Vintage PharmsMay 11, 2011
Wockhardt Eu OperatnJul 27, 1983
EcrAug 15, 2008
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DEXAMETHASONE INTENSOL [DexamethasoneC22H29FO5]
RX
-
1mg/ml (oral concentrate)
West-ward Pharms IntSep 1, 1983
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MAXIDEX [DexamethasoneC22H29FO5]
RX
-
0.1% (ophthalmic suspension/drops)
Novartis Pharms CorpApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OZURDEX [DexamethasoneC22H29FO5]
RX
-
0.7mg (intravitreal implant)
AllerganJun 17, 2009
  • Delivering an ocular implant as described in the dosage and administration section of the approved labeling of ozurdex.
  • Intravitreal treatment of diabetic macular edema.
  • Intravitreal treatment of macular edema following branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).
  • Treatment of macular edema.
  • Treatment of uveitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.